New Zealand markets closed

Agile Therapeutics, Inc. (AGRX)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
1.4100-0.0200 (-1.40%)
At close: 03:52PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-7,791
-14,465
-25,412
-71,067
-51,853
-
Depreciation & amortisation
396
386
1,534
2,223
276
-
Stock-based compensation
1,816
1,981
2,493
3,338
2,818
-
Change in working capital
2,705
7,417
-2,530
-2,853
107
-
Accounts receivable
-1,690
-15
-1,844
-668
-865
-
Inventory
-2,338
-2,207
-763
-6,289
0
-
Other working capital
-10,458
-9,577
-36,080
-65,471
-47,664
-
Other non-cash items
891
1,063
1,969
1,661
1,341
-
Net cash provided by operating activities
-10,458
-9,577
-35,947
-65,202
-47,311
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-133
-269
-353
-98
Purchases of investments
-
-
0
0
-54,837
0
Sales/maturities of investments
-
0
0
39,729
14,500
-
Net cash used for investing activities
0
0
-133
39,460
-40,690
-
Cash flows from financing activities
Debt repayment
-2,963
-1,347
-17,375
0
0
-
Common stock issued
7,232
8,235
35,430
30,347
48,434
-
Other financing activities
-
-
-
-
-1,059
-
Net cash used provided by (used for) financing activities
8,645
6,888
22,183
30,422
67,985
-
Net change in cash
-1,813
-2,689
-13,897
4,680
-20,016
-
Cash at beginning of period
4,429
5,246
19,143
14,463
34,479
-
Cash at end of period
2,616
2,557
5,246
19,143
14,463
-
Free cash flow
Operating cash flow
-10,458
-9,577
-35,947
-65,202
-47,311
-
Capital expenditure
-
-
-133
-269
-353
-98
Free cash flow
-10,458
-9,577
-36,080
-65,471
-47,664
-